|
West Coast Clinical
Trials, LLC Announces
their Newest Phase I
Location in Cypress, CA
Cypress, CA / March
2, 2007 /
--
West Coast Clinical
Trials, LLC is
pleased to announce the
opening of its newest
Phase I Research
facility in Cypress, CA.
The Cypress site is a
state-of-the-art, 30,000
square foot, overnight
facility with a capacity
of 120-beds. A second
Phase I site, located in
nearby Costa Mesa, CA,
has an overflow capacity
of 72-beds. The Cypress
facility also has an
additional 40,000 square
feet for potential
expansion of additional
Phase I pods.
?We are very excited
about our newest Phase I
research facility,? says
Dr. Kenneth Kim, CEO and
founder. ?Our new
facility will allow us
to better serve our
patients, sponsors and
the community.? ?We paid
close attention to
detail while designing
the Cypress facility so
that our clients, study
participants, and staff
will find the
environment enjoyable
and pleasant,? says Gary
Slizgi, VP, Business
Development & Strategy.
?We are looking forward
to our pharmaceutical
sponsors visiting our
new Cypress Phase I
research facility.?
WCCT will be
participating in the
ASCPT 2007Annual meeting
located at the Anaheim
Marriot Hotel. We will
be providing free
transportation to/from
WCCT from the Anaheim
Marriot beginning
Tuesday, March 20 thru
Saturday, March 24,
2007. For interested
sponsors that would like
to tour our site during
their visit to Southern
California, please
contact Andrea Newsom at
(562) 756-8657 to
schedule an appointment.
About West Coast
Clinical Trials, LLC.
WCCT is a full service,
Phase I CRO, with an
active adult and
pediatric unit
specializing in Asthma,
Allergy, Hypertension,
Diabetes, COPD, GI,
Nephrology, and other
therapeutic specialties.
Our specialties lie in
not only performing
healthy volunteer
studies, but special
population studies as
well. In addition, WCCT
can perform thorough QTc
studies, Telemetry,
Platelet Aggregometry,
Sleep (PSG), and
ethnicity studies
including
Japanese-Bridging.
WCCT has a proven track
record with several of
the major pharmaceutical
companies including, but
not limited to, Merck,
Pfizer, AstraZeneca,
Sanofi-Aventis, Novartis
and GlaxoSmithKline.
Over the last 9 years,
WCCT has conducted
hundreds of clinical
studies involving
thousands of patients
for nationally
recognized
pharmaceutical
companies.
WCCT is dedicated to
providing excellent
customer service to our
sponsors, patients, and
the community. Our
mission is to uphold our
high standards of
conducting quality
research while still a
high level of care to
our patients. Our focus
is to be the center of
excellence for bridging
medical research into
new therapies that
benefit lives.
For more information,
please visit
www.wcctrials.com.
_____________________
Contact:
Yves Grenon
Vice President, Business
Development
West Coast Clinical
Trials, LLC
5630 Cerritos Ave.
Cypress, CA 90630 USA
Phone:
(714) 252-0783
Fax: (714) 252-0799
E-mail:
yvesg@wcctrials.com
_____________________
Source: West Coast
Clinical Trials, LLC |